Britannia Life Sciences Cash Flow Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Net Income	-7.98	-4.77	5.08	-15.46	-0.16	-0.63
Depreciation & Amortization	0.18	0.23	0.16	0.19	0.04	-
Other Amortization	0.21	0.1	0.07	0	0	-
Loss (Gain) From Sale of Assets	-0.25	-0.47	-1.39	-	-	-
Loss (Gain) on Equity Investments	1.76	0.96	0.02	0	-	-
Stock-Based Compensation	-	0.23	1.05	1.11	-	-
Other Operating Activities	7.07	4.93	-2.57	16.5	0.22	-0.01
Change in Accounts Receivable	-0	0.56	0.2	-0.1	-0.24	-0.02
Change in Inventory	-0.07	0.07	-	-	-	-
Change in Accounts Payable	-0.16	0.24	-0.65	0.62	-0.45	0.17
Change in Other Net Operating Assets	0.35	0.01	0.04	-0.05	-	-
Operating Cash Flow	1.11	2.09	2.01	2.8	-0.59	-0.5
Operating Cash Flow Growth	-49.81%	4.15%	-28.26%	-	-	-
Capital Expenditures	-0.03	-0.13	-0.06	-0.09	0.04	-
Cash Acquisitions	0	-1.1	-2.98	0.74	-4.96	-
Sale (Purchase) of Intangibles	-0.43	-0.2	-0.29	-	-	-
Investing Cash Flow	-0.46	-1.44	-3.32	0.65	-4.91	-
Short-Term Debt Issued	-	0.03	-	0.12	0.23	-
Long-Term Debt Issued	-	-	7.98	1.41	6	-
Total Debt Issued	0.8	0.03	7.98	1.53	6.22	-
Short-Term Debt Repaid	-	-	-4.96	-3.44	-	-
Long-Term Debt Repaid	-	-2	-0.07	-0.08	-0.02	-
Total Debt Repaid	-2.26	-2	-5.03	-3.52	-0.02	-
Net Debt Issued (Repaid)	-1.46	-1.97	2.95	-1.99	6.2	-
Issuance of Common Stock	-	-	-	0	-	0.66
Other Financing Activities	-	-	-0.79	-0.6	-0	-0.01
Financing Cash Flow	-1.46	-1.97	2.16	-2.58	6.2	0.65
Foreign Exchange Rate Adjustments	0.08	0.05	0.13	-0.07	-0.02	-
Net Cash Flow	-0.73	-1.28	0.97	0.8	0.69	0.15
Free Cash Flow	1.09	1.96	1.95	2.71	-0.54	-0.5
Free Cash Flow Growth	-47.76%	0.19%	-27.99%	-	-	-
Free Cash Flow Margin	15.10%	25.85%	30.50%	37.16%	-38.15%	-
Free Cash Flow Per Share	0.01	0.01	0.01	0.03	-0.01	-0.08
Cash Interest Paid	-	-	0.79	-	-	-
Levered Free Cash Flow	5.36	6.16	0.43	1.79	0.41	-
Unlevered Free Cash Flow	6.11	6.96	0.96	3.24	0.63	-
Change in Net Working Capital	-5.62	-5.94	0.6	-1.02	-0.37	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.